この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
専門分野
サービス
職務経験
Research Fellow
University of Michigan Hospital
1月 2020 - 現在 ![]()
学歴
PhD (Biotechnology)
Indian Institute of Technology Madras
7月 2009 - 9月 2019 ![]()
MSc (Biotechnology)
Bharathiar University
2007 - 2009 ![]()
BSc (Biotechnology)
PSG College of Arts and Science
2004 - 2007 ![]()
Diploma in Diagnostics & Clinical Laboratory Management (Biochemistry)
PSG College of Arts and Science
2004 - 2006 ![]()
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Kim, Dae-Hwan, Sun, Duanchen, Storck, William K, Welker Leng, Katherine R, Jenkins, Chelsea, Coleman, Daniel J, Sampson, David A, Guan, Xiangnan, Kumaraswamy, Anbarasu, Rodansky, Eva S, et al. (2021). BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program . Clinical Cancer Research.
Kumaraswamy, Anbarasu, Leng, Katherine R. Welker, Westbrook, Thomas C., Yates, Joel A., Zhao, Shuang G., Evans, Christopher P., Feng, Felix Y., Morgan, Todd M., Alumkal, Joshi J. (2021). Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer . European Urology.
Coleman, Daniel J., Sampson, David A., Sehrawat, Archana, Kumaraswamy, Anbarasu, Sun, Duanchen, Wang, Yuzhuo, Schwartzman, Jacob, Urrutia, Joshua, Lee, Ahn R., Coleman, Ilsa M., et al. (2020). Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4 . Neoplasia.
Ananthi, S., Lakshmi, C.N.P., Atmika, P., Anbarasu, K., Mahalingam, S.(2018). Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma . Scientific Reports. 8. (1).
Kumaraswamy, Anbarasu and Mamidi, Anitha and Desai, Pavitra and Sivagnanam, Ananthi and Perumalsamy, Lakshmi Revathi and Ramakrishnan, Chandrasekaran and Gromiha, Michael and Rajalingam, Krishnaraj and Mahalingam, Sundarasamy(2018). The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function . Journal of Biological Chemistry. 293. (40). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 15691-15705.
Kowshik, J., Mishra, R., Sophia, J., Rautray, S., Anbarasu, K., Reddy, G.D., Dixit, M., Mahalingam, S., Nagini, S.(2017). Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model . Scientific Reports. 7. (1).
Thoompumkal, I.J., Rehna, K., Anbarasu, K., Mahalingam, S.(2016). Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation . Cell Cycle. 15. (23). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3251-3267.
Datta, D. and Anbarasu, K. and Rajabather, S. and Priya, R.S. and Desai, P. and Mahalingam, S.(2015). Nucleolar GTP-binding protein-1 (NGP-1) promotes G1to S phase transition by activating cyclin-dependent kinase inhibitor p21Cip1/Waf1 . Journal of Biological Chemistry. 290. (35). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 21536-21552.
Thoompumkal, I.J., Rao, M.R.K.S., Kumaraswamy, A., Krishnan, R., Mahalingam, S.(2015). GNL3L is a nucleo-cytoplasmic shuttling protein: Role in cell cycle regulation . PLoS ONE. 10. (8).
Suryaraja, R., Anitha, M., Anbarasu, K., Kumari, G., Mahalingam, S.(2013). The E3 ubiquitin ligase itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner . Cell Death and Disease. 4. (3).
Boddapati, N., Anbarasu, K., Suryaraja, R., Tendulkar, A.V., Mahalingam, S.(2012). Subcellular distribution of the human putative nucleolar GTPase GNL1 is regulated by a novel arginine/lysine-rich domain and a GTP binding domain in a cell cycle-dependent manner . Journal of Molecular Biology. 416. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 346-366.